Hyperion Defi (HYPD) Other Non Operating Income (2021 - 2026)
Hyperion Defi (HYPD) posted quarterly Other Non Operating Income of $90133.0 for Q1 2026, up 2344.62% year-over-year from $3687.0 in Q1 2025, and up 5.25% quarter-over-quarter from $85633.0 in Q4 2025.
Hyperion Defi (HYPD) Other Non Operating Income (2021 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Other Non Operating Income for 6 consecutive years, with $90133.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 2344.62% year-over-year to $90133.0; the TTM figure through Mar 2026 stood at $476131.0 (up 4373.23% YoY), while the FY2025 annual figure was $389685.0, up 530.11% from the prior year.
- Other Non Operating Income rose to $90133.0 in Q1 2026 per HYPD's latest filing, from $85633.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $168840.0 in Q2 2025 and bottomed at -$348226.0 in Q3 2023.
- Historically, Other Non Operating Income has averaged $24111.5 across 5 years, with a median of $33376.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 595.5% — and 2025, when it soared 11008.53%.
- Hyperion Defi's Other Non Operating Income stood at $100510.0 in 2022, then sank by 118.53% to -$18628.0 in 2023, then jumped by 114.99% to $2793.0 in 2024, then surged by 2965.99% to $85633.0 in 2025, then grew by 5.25% to $90133.0 in 2026.
- Business Quant data shows HYPD's Other Non Operating Income at $90133.0 in Q1 2026, $85633.0 in Q4 2025, and $131525.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112,032.00 |
| Mar 31, 2026 | 90,133.00 |
| Dec 31, 2025 | 85,633.00 |
| Sep 30, 2025 | 131,525.00 |
| Jun 30, 2025 | 168,840.00 |
| Mar 31, 2025 | 3,687.00 |
| Dec 31, 2024 | 2,793.00 |
| Sep 30, 2024 | 1,184.00 |
| Jun 30, 2024 | 2,980.00 |
| Mar 31, 2024 | -97,558.00 |
| Dec 31, 2023 | -18,628.00 |
| Sep 30, 2023 | -348,226.00 |
| Jun 30, 2023 | 119,450.00 |
| Mar 31, 2023 | 70,993.00 |
| Dec 31, 2022 | 100,510.00 |
| Sep 30, 2022 | 70,277.00 |
| Jun 30, 2022 | 33,376.00 |
| Mar 31, 2022 | -7,073.00 |
| Sep 30, 2021 | 463,353.00 |
| Jun 30, 2021 | 18,566.00 |